281
Participants
Start Date
June 16, 2015
Primary Completion Date
November 30, 2019
Study Completion Date
November 30, 2029
Autologous Stem Cell Transplant (ASCT)
Randomisation to melphalan conditioned autologous stem cell transplant
Consolidation with 4 cycles of CarCyDex
Randomisation to 4 further cycles of Carfilzomib, Cyclophosphamide and Dexamethasone for responding patients following 4 cycles of induction chemotherapy
Queen's Hospital, Romford
Royal United Hospital, Bath
Birmingham Heartlands Hospital, Birmingham
NHS Lanarkshire, Bothwell
Bradford Royal Infirmary, Bradford
University College London Hospital, London
Maidstone and Tunbridge Wells, Maidstone
Royal Stoke University Hospital, Stoke
City Hospital Sunderland, Sunderland
Kent and Canterbury Hospital, Canterbury
University Hospital of Wales, Cardiff
Medway NHS Foundation Trust, Gillingham
St James' Hospital, Leeds
St Bartholomew's Hospital, London
Barnet Hospital, London
Guy's Hospital, London
King's College Hospital, London
St George's Hospital, London
Churchill Hospital, Oxford
Royal Hallamshire Hospital, Sheffield
Collaborators (1)
Amgen
INDUSTRY
University College, London
OTHER